Surveillance report updates tuberculosis elimination progress and program performance in the United States from 2016 to 2022

This surveillance report describes progress toward tuberculosis elimination and tuberculosis program performance in the United States from 2016 to 2022. The report provides an update on these metrics but does not specify the study population, sample size, intervention or exposure, comparator, or setting beyond the United States.

The main outcome assessed was progress toward tuberculosis elimination and tuberculosis program performance. The result is described as an 'update provided' for the period 2016-2022. No effect sizes, absolute numbers, p-values, confidence intervals, or direction of change are reported. Safety and tolerability data are not reported.

Key limitations include the absence of quantitative results, population details, and methodological specifics. The report's practice relevance is not reported. This document serves as a descriptive status update rather than a comparative effectiveness study. Clinicians should view it as an administrative summary requiring consultation of detailed surveillance data for specific insights into tuberculosis trends or program outcomes.